Dendreon Corporation (DNDN)

14.17 +0.23  +1.65%  Feb 03, 11:00PM Go Pro
Watch
View Full Chart DNDN Price Chart

Key Stats

Market Cap 2.11B
Revenue Growth 217.95%
Profit Margin -228.83%
Earnings Yield -16.23%
Dividend Yield 0.00%
Earnings Per Share TTM -2.30
PE Ratio
Price / Sales Ratio 12.64
52 Week High 43.96
52 Week Low 6.46
Beta 3.79
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

Feb 04 According to my analysis of $DNDN history with Full STO, we should move much higher soon http://chart.ly/lgcxnta by jman1204
Feb 04 BOA see's "Increased probability for success" with upgrading $DNDN HIGH demand for Provenge, higher prices soon, get in now..Rev= tripled. by ByHighSellHigher
Feb 04 BOA see's "Increased probability for sucess" with upgrading $DNDN HIGH demand for Provenge, last Q tripled in Rev, stock is winding up. by ByHighSellHigher
Feb 04 $DNDN really does look spring loaded for a run this month, chart is yummy by DoinWerk
Feb 04 Beautiful Bull Flag and also a coil that's about to unwind. I would use caution shorting below $15. $DNDN http://chart.ly/rp2etsj by jettzero
Feb 04 $DNDN http://stks.co/2FL6 Basing here nicely - Sneaky buy above $14.71, but breakout is clear above $15.21 by ChartSwingTrade
Feb 04 $DNDN http://stks.co/2FKy Huge short interest and getting tight now. A big move is coming. See if clears 14.75 this week by traderstewie
Feb 03 $SODA $DNDN $VRTX $ACHN $CLDX $IDIX Holding long, Great upside opp.....Patience, Patience.....Have GREAT weekend....Go Pats...!! by ByHighSellHigher
Feb 03 $DNDN Printed an NR7, again. Last was 5 days ago... This thing is spring loaded. by onpaper
Feb 03 What's Going on With These Biotech Stocks?
Feb 03 This Just In: Upgrades and Downgrades
Feb 03 Overreacting to a Prostate Cancer Drug? Investor Place
Feb 03 Notable Analyst Rating Changes 02/03: (DNDN) (BBT) (NOV) Upgraded; (RIMM) (VRTX) (AET...
Feb 03 Pre-Open Movers 2/3: (ZOLG) (GILD) (URBN) Higher; (THQI) (EW) (APKT) Lower (more...) Street Insider

Profile

Exchange: NASDAQGM       Sector: Healthcare       Industry: Biotechnology

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Dendreon Corporation is down N/A over the last year vs S&P 500 Total Return up N/A, Human Genome Sciences down N/A, and Medivation up N/A.

  • DNDN Total Returns
  • ^SPXTR Total Returns
  • HGSI Total Returns
  • MDVN Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Balance Sheet View Statement

Cash Flow Statement View Statement

Get Quote for

Pro Strategies Featuring DNDN

Did Dendreon Corporation make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

DNDN Related Topics

DNDN Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
DNDN 14.17 0.23 1.65% 2.11B
OPEN 52.00 1.59 3.16% 1.23B
TRLG 36.18 -0.04 -0.11% 931.63M
EZPW 29.58 0.52 1.79% 1.40B
SKS 10.58 0.58 5.80% 1.69B
FNSR 21.59 1.20 5.89% 1.96B
OVTI 15.77 0.47 3.07% 940.05M
PWER 5.28 0.76 16.81% 548.01M
SCHN 45.56 1.21 2.73% 1.24B
NFLX 126.43 2.43 1.96% 7.00B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close